Pogue Mahone
The caf's Camus.
Dunno what their sources are but they’re predicting that the EMA won’t give a license for use in >65yo because they were so poorly represented in the trials (and evidently didn’t get a great response)AZ vaccine only 8% effective in over 65s?
Corona-News am Montag: AstraZeneca-Impfstoff laut Bericht bei Risikogruppe kaum wirksam - DER SPIEGEL
It does fit with how they supposedly got their best efficacy in the half dose/full dose cohort. That cohort were all under 55 (can’t remember exactly, if not all then most?) so it was always a possibility that dose was a red herring and being young the main driver for good efficacy.
Such a fecking mess though. Really poor effort at running a phase III program.